Ellenberger, David

[["dc.bibliographiccitation.firstpage","1641"],["dc.bibliographiccitation.issue","12"],["dc.bibliographiccitation.journal","Multiple Sclerosis Journal"],["dc.bibliographiccitation.lastpage","1652"],["dc.bibliographiccitation.volume","25"],["dc.contributor.author","Rommer, Paulus Stefan"],["dc.contributor.author","Eichstädt, Kerstin"],["dc.contributor.author","Ellenberger, David"],["dc.contributor.author","Flachenecker, Peter"],["dc.contributor.author","Friede, Tim"],["dc.contributor.author","Haas, Judith"],["dc.contributor.author","Kleinschnitz, Christoph"],["dc.contributor.author","Pöhlau, Dieter"],["dc.contributor.author","Rienhoff, Otto"],["dc.contributor.author","Stahmann, Alexander"],["dc.contributor.author","Zettl, Uwe Klaus"],["dc.date.accessioned","2020-12-10T18:38:31Z"],["dc.date.available","2020-12-10T18:38:31Z"],["dc.date.issued","2018"],["dc.identifier.doi","10.1177/1352458518799580"],["dc.identifier.eissn","1477-0970"],["dc.identifier.issn","1352-4585"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/77349"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","173"],["dc.bibliographiccitation.journal","Multiple Sclerosis and Related Disorders"],["dc.bibliographiccitation.lastpage","174"],["dc.bibliographiccitation.volume","25"],["dc.contributor.author","Ellenberger, David"],["dc.contributor.author","Eichstädt, Kerstin"],["dc.contributor.author","Flachenecker, Peter"],["dc.contributor.author","Friede, Tim"],["dc.contributor.author","Haas, Judith"],["dc.contributor.author","Kleinschnitz, Christoph"],["dc.contributor.author","Pöhlau, Dieter"],["dc.contributor.author","Rienhoff, Otto"],["dc.contributor.author","Stahmann, Alexander"],["dc.contributor.author","Zettl, Uwe K"],["dc.contributor.author","Rommer, Paulus S"],["dc.date.accessioned","2020-12-10T15:20:23Z"],["dc.date.available","2020-12-10T15:20:23Z"],["dc.date.issued","2018"],["dc.identifier.doi","10.1016/j.msard.2018.07.040"],["dc.identifier.issn","2211-0348"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/72654"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Decreasing longitudinal use of glucocorticosteroids in multiple sclerosis"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","436"],["dc.bibliographiccitation.issue","07"],["dc.bibliographiccitation.journal","Fortschritte der Neurologie · Psychiatrie"],["dc.bibliographiccitation.lastpage","450"],["dc.bibliographiccitation.volume","88"],["dc.contributor.author","Flachenecker, Peter"],["dc.contributor.author","Eichstädt, Kerstin"],["dc.contributor.author","Berger, Klaus"],["dc.contributor.author","Ellenberger, David"],["dc.contributor.author","Friede, Tim"],["dc.contributor.author","Haas, Judith"],["dc.contributor.author","Kleinschnitz, Christoph"],["dc.contributor.author","Pöhlau, Dieter"],["dc.contributor.author","Rienhoff, Otto"],["dc.contributor.author","Stahmann, Alexander"],["dc.contributor.author","Zettl, Uwe K."],["dc.date.accessioned","2021-04-14T08:25:41Z"],["dc.date.available","2021-04-14T08:25:41Z"],["dc.date.issued","2020"],["dc.identifier.doi","10.1055/a-0985-4124"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/81707"],["dc.language.iso","de"],["dc.notes.intern","DOI Import GROB-399"],["dc.relation.eissn","1439-3522"],["dc.relation.issn","0720-4299"],["dc.title","Multiple Sklerose in Deutschland: aktualisierte Auswertungen des MS-Registers der DMSG 2014–2018"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","589"],["dc.bibliographiccitation.journal","Multiple Sclerosis Journal"],["dc.bibliographiccitation.lastpage","590"],["dc.bibliographiccitation.volume","22"],["dc.contributor.author","Stahmann, Alexander"],["dc.contributor.author","Buckow, Karoline"],["dc.contributor.author","Ellenberger, David"],["dc.contributor.author","Heymann, D."],["dc.contributor.author","Mai, M."],["dc.contributor.author","Meissner, Thomas"],["dc.contributor.author","Zettl, Uwe K."],["dc.date.accessioned","2018-11-07T10:08:50Z"],["dc.date.available","2018-11-07T10:08:50Z"],["dc.date.issued","2016"],["dc.description.sponsorship","Merck Serono; Biogen Idec; Bayer; Genzyme; Novartis; TEVA Sanofi"],["dc.identifier.isi","000383267202338"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/39545"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Sage Publications Ltd"],["dc.publisher.place","London"],["dc.relation.conference","32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)"],["dc.relation.eventlocation","London, ENGLAND"],["dc.relation.issn","1477-0970"],["dc.relation.issn","1352-4585"],["dc.title","The German MS Register: update on immunotherapy"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.artnumber","13340"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","Scientific Reports"],["dc.bibliographiccitation.volume","11"],["dc.contributor.author","Ohle, Lisa-Marie"],["dc.contributor.author","Ellenberger, David"],["dc.contributor.author","Flachenecker, Peter"],["dc.contributor.author","Friede, Tim"],["dc.contributor.author","Haas, Judith"],["dc.contributor.author","Hellwig, Kerstin"],["dc.contributor.author","Parciak, Tina"],["dc.contributor.author","Warnke, Clemens"],["dc.contributor.author","Paul, Friedemann"],["dc.contributor.author","Stahmann, Alexander"],["dc.date.accessioned","2021-08-12T07:45:01Z"],["dc.date.available","2021-08-12T07:45:01Z"],["dc.date.issued","2021"],["dc.description.abstract","Abstract In 2001, the German Multiple Sclerosis Society, facing lack of data, founded the German MS Registry (GMSR) as a long-term data repository for MS healthcare research. By the establishment of a network of participating neurological centres of different healthcare sectors across Germany, GMSR provides observational real-world data on long-term disease progression, sociodemographic factors, treatment and the healthcare status of people with MS. This paper aims to illustrate the framework of the GMSR. Structure, design and data quality processes as well as collaborations of the GMSR are presented. The registry’s dataset, status and results are discussed. As of 08 January 2021, 187 centres from different healthcare sectors participate in the GMSR. Following its infrastructure and dataset specification upgrades in 2014, more than 196,000 visits have been recorded relating to more than 33,000 persons with MS (PwMS). The GMSR enables monitoring of PwMS in Germany, supports scientific research projects, and collaborates with national and international MS data repositories and initiatives. With its recent pharmacovigilance extension, it aligns with EMA recommendations and helps to ensure early detection of therapy-related safety signals."],["dc.description.abstract","Abstract In 2001, the German Multiple Sclerosis Society, facing lack of data, founded the German MS Registry (GMSR) as a long-term data repository for MS healthcare research. By the establishment of a network of participating neurological centres of different healthcare sectors across Germany, GMSR provides observational real-world data on long-term disease progression, sociodemographic factors, treatment and the healthcare status of people with MS. This paper aims to illustrate the framework of the GMSR. Structure, design and data quality processes as well as collaborations of the GMSR are presented. The registry\\’s dataset, status and results are discussed. As of 08 January 2021, 187 centres from different healthcare sectors participate in the GMSR. Following its infrastructure and dataset specification upgrades in 2014, more than 196,000 visits have been recorded relating to more than 33,000 persons with MS (PwMS). The GMSR enables monitoring of PwMS in Germany, supports scientific research projects, and collaborates with national and international MS data repositories and initiatives. With its recent pharmacovigilance extension, it aligns with EMA recommendations and helps to ensure early detection of therapy-related safety signals."],["dc.identifier.doi","10.1038/s41598-021-92722-x"],["dc.identifier.pii","92722"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/88352"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-448"],["dc.relation.eissn","2045-2322"],["dc.title","Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]